📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors. (2024)

First Author: Novaes GM

Attributed to: Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’ funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ymthe.2024.01.006

PubMed Identifier: 38213031

Publication URI: http://europepmc.org/abstract/MED/38213031

Type: Journal Article/Review

Volume: 32

Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy

Issue: 2

ISSN: 1525-0016